Compounds > troglitazone
Page last updated: 2024-11-05

troglitazone and Ischemia

troglitazone has been researched along with Ischemia in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garg, R1
Kumbkarni, Y1
Aljada, A1
Mohanty, P1
Ghanim, H1
Hamouda, W1
Dandona, P1

Other Studies

1 other study available for troglitazone and Ischemia

ArticleYear
Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:3

    Topics: Adult; Antioxidants; Brachial Artery; Chromans; Female; Humans; Hypertension; Ischemia; Leukocytes,

2000